Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 10-12G Registration of securities
- 2.1 Exhibit 2.1
- 2.2 Exhibit 2.2
- 2.3 Exhibit 2.3
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 4.3 Exhibit 4.3
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 16.1 Exhibit 16.1
- 21.1 Exhibit 21.1
LXXGQ similar filings
Filing view
External links
Exhibit 16.1
June 22, 2022
Securities and Exchange Commission
Washington, D.C. 20549
Ladies and Gentlemen:
We, Manning Elliott LLP, were previously the auditor for LexaGene Holdings Inc. (the "Company") and, under the date of June 26, 2020, we reported on the consolidated financial statements of the Company as of and for the year ended February 29, 2020. Manning Elliott LLP resigned as the Company’s auditor effective May 7, 2021.
We have read the Company’s statements included in Item 14 of its Form 10 under the heading “Changes in and Disagreements with Auditors on Accounting and Financial Disclosure” and we agree with such statements.
Very truly yours,
/s/ Manning Elliott LLP
Manning Elliott LLP
Chartered Professional Accountants